Development and Preclinical Evaluation of [211At]PSAt-3-Ga: An Inhibitor for Targeted α-Therapy of Prostate Cancer.
El Fakiri M, Ayada N, Müller M, Hvass L, Gamzov TH, Clausen AS, Geis NM, Steinacker N, Hansson E, Lindegren S, Aneheim E, Jensen H, Eder AC, Jensen AI, Poulie CBM, Kjaer A, Eder M, Herth MM.
El Fakiri M, et al. Among authors: steinacker n.
J Nucl Med. 2024 Apr 1;65(4):593-599. doi: 10.2967/jnumed.123.267043.
J Nucl Med. 2024.
PMID: 38423784